Bio-Rad Launches Exact Diagnostics Transplant Quality Control Product Line in European Market
Bio-Rad Laboratories, a global provider of life science research and clinical diagnostics products, announces the launch of its Exact Diagnostics transplant product line consisting of molecular standards and quality controls to laboratories in Europe.
This range of unassayed controls and verification panels enable labs to establish points of reference and monitor the presence of pathogens found commonly before, during and after transplant procedures.
Bio-Rad’s Exact Diagnostics Transplant molecular quality controls and standards deliver traceability, commutability and ddPCR quantification to high-impact molecular testing. The products utilize reference material quantified with droplet digital PCR, providing laboratory staff with confidence needed to ensure that testing instruments are performing with consistent results.
The Exact Diagnostic Transplant product range include QC products and standards for:
All products from the transplant portfolio are available now in Europe. To learn more click here
This range of unassayed controls and verification panels enable labs to establish points of reference and monitor the presence of pathogens found commonly before, during and after transplant procedures.
Bio-Rad’s Exact Diagnostics Transplant molecular quality controls and standards deliver traceability, commutability and ddPCR quantification to high-impact molecular testing. The products utilize reference material quantified with droplet digital PCR, providing laboratory staff with confidence needed to ensure that testing instruments are performing with consistent results.
The Exact Diagnostic Transplant product range include QC products and standards for:
- Adenovirus
- BK Virus (BKV)
- Parvovirus B19
- Cytomegalovirus (CMV)
- Epstein-Barr Virus (EBV)
- Human Herpesvirus 6 (HHV-6)
- Herpes Simplex 1 (HSV-1)
- Herpes Simplex 2 (HSV-2)
- John Cunningham Virus (JCV)
- Varicella-Zoster Virus (VZV)
All products from the transplant portfolio are available now in Europe. To learn more click here
